BI Asset Management Fondsmaeglerselskab A S Buys 594 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

BI Asset Management Fondsmaeglerselskab A S lifted its stake in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 34.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,322 shares of the medical device company’s stock after acquiring an additional 594 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Cooper Companies were worth $879,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas grew its holdings in Cooper Companies by 2.5% in the 3rd quarter. Teacher Retirement System of Texas now owns 3,834 shares of the medical device company’s stock valued at $1,219,000 after buying an additional 95 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. increased its position in Cooper Companies by 4.7% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,249 shares of the medical device company’s stock worth $397,000 after acquiring an additional 56 shares during the period. Signaturefd LLC boosted its holdings in Cooper Companies by 12.5% in the 3rd quarter. Signaturefd LLC now owns 1,388 shares of the medical device company’s stock valued at $441,000 after purchasing an additional 154 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Cooper Companies by 90.6% in the 3rd quarter. Assenagon Asset Management S.A. now owns 13,824 shares of the medical device company’s stock valued at $4,396,000 after purchasing an additional 6,572 shares during the period. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its holdings in shares of Cooper Companies by 14.0% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 47,459 shares of the medical device company’s stock worth $15,092,000 after purchasing an additional 5,821 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Citigroup boosted their price target on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Mizuho upped their price objective on Cooper Companies from $102.50 to $115.00 and gave the company a “buy” rating in a research note on Friday, March 1st. KeyCorp started coverage on shares of Cooper Companies in a research note on Tuesday, February 6th. They issued a “sector weight” rating on the stock. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $100.00 to $120.00 in a research report on Wednesday, March 13th. Finally, Redburn Atlantic upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price target on the stock in a research report on Tuesday, March 19th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $109.69.

Get Our Latest Stock Report on COO

Cooper Companies Stock Down 0.2 %

NASDAQ:COO opened at $96.60 on Thursday. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $104.07. The company has a quick ratio of 1.08, a current ratio of 1.86 and a debt-to-equity ratio of 0.35. The stock’s 50 day moving average price is $95.71 and its two-hundred day moving average price is $93.24. The firm has a market capitalization of $19.20 billion, a price-to-earnings ratio of 66.05, a price-to-earnings-growth ratio of 2.45 and a beta of 0.97.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its earnings results on Thursday, February 29th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.07. The business had revenue of $931.60 million during the quarter, compared to the consensus estimate of $915.93 million. Cooper Companies had a net margin of 7.93% and a return on equity of 8.79%. Cooper Companies’s revenue was up 8.5% on a year-over-year basis. During the same period last year, the business posted $2.90 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 3.5 earnings per share for the current fiscal year.

Insider Transactions at Cooper Companies

In other news, CAO Agostino Ricupati sold 54,724 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the transaction, the chief accounting officer now directly owns 5,081 shares of the company’s stock, valued at $512,622.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Gary S. Petersmeyer sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $103.51, for a total transaction of $103,510.00. Following the transaction, the director now directly owns 5,668 shares of the company’s stock, valued at $586,694.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 54,724 shares of Cooper Companies stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $100.89, for a total transaction of $5,521,104.36. Following the completion of the sale, the chief accounting officer now owns 5,081 shares of the company’s stock, valued at $512,622.09. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by corporate insiders.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.